Pasithea Therapeutics Corp. (KTTAW) News
Follow Pasithea Therapeutics Corp. (KTTAW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Pasithea Therapeutics Receives FDA IND Clearance for PAS-004
FDA clearance allows the company to advance PAS-004 for neurofibromatosis type 1-associated cutaneous neurofibromas.
REGULATION | Nov 03, 2026, 12:09 PM UTC
L
KTTAW Pasithea Therapeutics to participate in two September 2026 conferences
Pasithea Therapeutics, tied to KTTAW, announced participation in two investor conferences in September 2026.
EQUITY | Sep 03, 2026, 08:08 PM UTC